BRIDGEWAY CAPITAL MANAGEMENT, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 64 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$421,686
+0.2%
34,2000.0%0.01%0.0%
Q2 2023$420,660
+0.1%
34,2000.0%0.01%
-9.1%
Q1 2023$420,318
+7.2%
34,2000.0%0.01%
+10.0%
Q4 2022$391,932
+206.2%
34,2000.0%0.01%
+233.3%
Q3 2022$128,000
-63.6%
34,200
-42.2%
0.00%
-62.5%
Q2 2022$352,000
-5.9%
59,2000.0%0.01%
+14.3%
Q1 2022$374,000
+61.9%
59,2000.0%0.01%
+75.0%
Q4 2021$231,000
-19.2%
59,2000.0%0.00%
-20.0%
Q3 2021$286,000
-24.3%
59,2000.0%0.01%
-28.6%
Q2 2021$378,000
-6.2%
59,200
-7.8%
0.01%
-12.5%
Q1 2021$403,000
-5.2%
64,200
+4.1%
0.01%
-11.1%
Q4 2020$425,000
+72.1%
61,7000.0%0.01%
+50.0%
Q3 2020$247,000
+20.5%
61,7000.0%0.01%
+50.0%
Q2 2020$205,000
+54.1%
61,7000.0%0.00%
+33.3%
Q1 2020$133,000
-31.4%
61,7000.0%0.00%0.0%
Q4 2019$194,000
-30.0%
61,7000.0%0.00%
-25.0%
Q3 2019$277,000
-25.7%
61,7000.0%0.00%
-20.0%
Q2 2019$373,000
+100.5%
61,700
+131.1%
0.01%
+150.0%
Q1 2019$186,000
-44.8%
26,700
-57.8%
0.00%
-33.3%
Q3 2018$337,000
+8.7%
63,2000.0%0.00%0.0%
Q2 2018$310,00063,2000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Newtyn Management, LLC 362,335$3,714,0000.57%
Rubric Capital Management LP 410,244$4,205,0000.52%
WITTENBERG INVESTMENT MANAGEMENT, INC. 83,811$859,0000.37%
Yakira Capital Management, Inc. 83,969$861,0000.28%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$153,0000.10%
STONEBRIDGE CAPITAL MANAGEMENT INC 18,550$200,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 66,498$681,0000.05%
Cannell & Co. 75,467$774,0000.03%
Trexquant Investment LP 21,347$219,0000.02%
PDT Partners, LLC 58,004$595,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders